{"id":"W2132932769","doi":"10.1586/14737167.4.2.143","title":"Levetiracetam: an innovative and cost-effective add-on drug for refractory partial epilepsy","year":2004,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Levetiracetam; Tolerability; Medicine; Epilepsy; Quality of life (healthcare); Intensive care medicine; Regimen; Adverse effect; Pediatrics; Psychiatry; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009682182,0.0003664917,0.0003294648,0.0004315535,0.0001187274,0.00030982,0.0004052225,0.0004775843,0.002413503],"category_scores_gemma":[0.00014904,0.00006206203,0.0003404219,0.0002774521,0.000143808,0.0003154673,0.000270548,0.0004837018,0.0009115339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004501873,"about_ca_system_score_gemma":0.0002941691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000638749,"about_ca_topic_score_gemma":0.002440305,"domain_scores_codex":[0.9999257,0.00001381191,0.000006659247,0.00001005788,0.00003171452,0.00001197581],"domain_scores_gemma":[0.9999578,0.000005005603,0.0000100293,0.000003182289,0.000005401916,0.00001867304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00361178,0.001044708,0.001651952,0.0007580332,0.0000993219,0.004099078,0.00006105807,0.0009212238,0.08612925,0.0014495,0.009288994,0.890885],"study_design_scores_gemma":[0.01604158,0.04637901,0.08801506,0.000703626,0.001411492,0.081904,0.0002386894,0.01264522,0.1420937,0.004219285,0.6060638,0.0002846039],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7606648,0.15411,0.01948824,0.01343671,0.001118517,0.000952226,0.001816122,0.001852114,0.04656138],"genre_scores_gemma":[0.9328321,0.04218582,0.0100387,0.001797895,0.0005706122,0.0001613828,0.001052072,0.00005362977,0.01130781],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002413503,"threshold_uncertainty_score":0.008073986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07345537034517131,"score_gpt":0.5465840953544802,"score_spread":0.4731287250093089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}